Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

GH secretagogues under development at Merck & Co.

Nov. 24, 1997

Clinical trial demonstrates efficacy of NPS-R-568 in hyperparathyroidism

Nov. 24, 1997

Olpadronate associated with improvement in osteogenesis imperfecta

Nov. 24, 1997

Amylin, SIDDCO join forces for metabolic drug discovery

Nov. 21, 1997

Novel agent for insulin resistance, S-15261, evaluated in rat model

Nov. 21, 1997

Spotlight on selective estrogen receptor modulators

Nov. 21, 1997

Torii reveals antidiabetic thiazolidinediones

Nov. 21, 1997

Japanese researchers develop new animal model of obesity

Nov. 21, 1997

FDA advisory committee recommends approval of Prandin

Nov. 20, 1997

New ACAT inhibitor from Pierre Fabre

Nov. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...